EDGAR Filing Documents for 0001193125-19-293624

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001193125-19-293624

Filing Date

2019-11-18

Accepted

2019-11-15 20:15:05

Documents

Period of Report

2019-11-15

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	d834506d6k.htm	6-K	12364
2	EX-99.1	d834506dex991.htm	EX-99.1	1088450
3	EX-99.2	d834506dex992.htm	EX-99.2	13966
4	EX-99.3	d834506dex993.htm	EX-99.3	16222
5	EX-99.4	d834506dex994.htm	EX-99.4	45300
6	EX-99.5	d834506dex995.htm	EX-99.5	54792
7	EX-99.6	d834506dex996.htm	EX-99.6	67590
8	GRAPHIC	g834506dsp119.jpg	GRAPHIC	3096
9	GRAPHIC	g834506dsp143a.jpg	GRAPHIC	3447
10	GRAPHIC	g834506g1114233736780.jpg	GRAPHIC	2708
	Complete submission text file	0001193125-19-293624.txt		1313003

Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4

Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 514-341-2115

Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)